A CU Medicine provider.
My clinical interests include the diagnosis and management of Interstitial Lung Diseases, as well as care of critically ill patients in the Medical Intensive Care Unit.
Interstitial lung diseases are complex group of over 100 rare disorders, including idiopathic pulmonary fibrosis, autoimmune or connective tissue disease-related interstitial lung disease and hypersensitivity pneumonitis being the most common. ILDs are often associated with significant morbidity and mortality. Our group strives to provide comprehensive care for patients with ILD using a multi-disciplinary and multi-dimensional approach to care and research.
In the Intensive Care Unit, I diagnose and treat complex critically ill of patients with a wide variety of complex medical conditions, ranging from respiratory failure to septic shock to gastrointestinal bleeding to severe electrolyte and metabolic derangements.
In all of my practice settings, I value the opportunity to work with patients and their families. I endeavor to apply rigorous attention to detail, a focus on evidence-based medicine, and a collaborative focus on treatments and interventions.
Locations
720.848.0748Qualifications and experience
- Specialties
- Pulmonary Disease, Critical Care Medicine, Lungs and Breathing, Lungs and Breathing - Interstitial Lung Disease, Critical Care
- Gender
- Female
- Languages spoken
-
English
- Education
-
Fellowship
University of Colorado (University Hospital) Program (2014)
Medical School
Vanderbilt University School of Medicine (2007)
Residency
Vanderbilt University Program (2010)
Undergraduate
University of North Carolina–Chapel Hill (NC) (2003)
- Clinical interest for patients
-
Internal Medicine ( 2010 )
Pulmonary Disease ( 2012 )
Critical Care Medicine ( 2014 ) - Research interest for patients
-
My research focuses on understanding the molecular mechanisms that contribute to the formation of scar tissue in the lungs (pulmonary fibrosis). I have particular interests in fibrosis that develops following an infection (such as COVID or influenza) or ARDS, and understanding how these processes are both different and similar to more chronic forms of pulmonary fibrosis, such as Idiopathic Pulmonary Fibrosis (IPF). In my lab, we use cell culture, animal models of lung injury and fibrosis, and human samples that help bridge the gap between the bench and the bedside.
- Insurance
- UCHealth strongly encourages you to consult with your health insurer to determine accurate information about your coverage and benefits for a particular health care service provided at a UCHealth facility. Read more here.